Prognostic evaluation of cutaneous malignant melanoma: A clinicopathologic and immunohistochemical study

被引:0
作者
Niezabitowski, A
Czajecki, K
Rys, J
Kruczak, A
Gruchala, A
Wasilewska, A
Lackowska, B
Sokolowski, A
Szklarski, WA
机构
[1] Ctr Oncol, Dept Pathol, PL-31115 Krakow, Poland
[2] Mil Hosp, Dept Pathol, Krakow, Poland
[3] Univ Econ, Dept Stat, Krakow, Poland
关键词
malignant melanoma; stage of the disease; histology; immunohistochemistry; proliferative activity;
D O I
10.1002/(SICI)1096-9098(199903)70:3<150::AID-JSO2>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: Depth of invasion and stage of the disease are established prognostic indicators in cutaneous malignant melanoma. The role of other parameters is still, an open problem. Methods: In 93 consecutive patients with cutaneous malignant melanoma, the level of invasion, tumor thickness,ulceration, vascular invasion, lymphoplasmocytic infiltrates, and mitotic index were evaluated by histology. Expression of Ki-67 and PCNA proliferative antigens together with vimentin, S100, and HMB 45 proteins were assessed by immunohistochemistry. Results and Conclusions: Disease-free and overall survival were correlated with tumor stage, tumor thickness, level of invasion, macroscopic pattern, ulceration, vascular invasion, expression of HMB 45, PCNA, and Ki-67/MIB1. Stage, HMB 45, and PCNA were independent prognostic factors for disease-free survival, whereas tumor stage, tumor thickness, and expression of both proliferative antigens influenced overall survival independently. The variables studied demonstrated reciprocal correlation; therefore, analysis of many prognostic parameters in malignant melanoma could be recommended. J. Surg. Oncol. 1999:70:150-160. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:150 / 160
页数:11
相关论文
共 55 条
  • [1] Prognosis of thin cutaneous head and neck melanoma (<1 mm)
    Andersson, AP
    Dahlstrom, KK
    Drzewiecki, KT
    [J]. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (01): : 55 - 57
  • [2] AGE AS A PROGNOSTIC FACTOR IN THE MALIGNANT-MELANOMA POPULATION
    AUSTIN, PF
    CRUSE, CW
    LYMAN, G
    SCHROER, K
    GLASS, F
    REINTGEN, DS
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1994, 1 (06) : 487 - 494
  • [3] Barnhill RL, 1996, CANCER-AM CANCER SOC, V78, P427
  • [4] Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: A case-control study
    Bataille, V
    Bishop, JAN
    Sasieni, P
    Swerdlow, AJ
    Pinney, E
    Griffiths, K
    Cuzickz, J
    [J]. BRITISH JOURNAL OF CANCER, 1996, 73 (12) : 1605 - 1611
  • [5] MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma
    Boni, R
    Doguoglu, A
    Burg, G
    Muller, B
    Dummer, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (03) : 416 - 418
  • [6] BUTTNER P, 1995, CANCER-AM CANCER SOC, V75, P2499, DOI 10.1002/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO
  • [7] 2-8
  • [8] PROGNOSTIC VALUE OF SIZE OF LYMPH-NODE METASTASES IN PATIENTS WITH CUTANEOUS MELANOMA
    BUZAID, AC
    TINOCO, LA
    JENDIROBA, D
    TU, ZN
    LEE, JJ
    LEGHA, SS
    ROSS, MI
    BALCH, CM
    BENJAMIN, RS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2361 - 2368
  • [9] Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO
  • [10] 2-5